kth.sePublications KTH
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Millimeter-scale implantable device for continuous in vivo tracking of tumor growth via fluorescence sensing
KTH, School of Electrical Engineering and Computer Science (EECS), Micro and Nanosystems.ORCID iD: 0009-0007-6016-3708
KTH, School of Electrical Engineering and Computer Science (EECS), Micro and Nanosystems. MedTechLabs, BioClinicum, Karolinska University Hospital, Solna 171 64, Sweden.ORCID iD: 0009-0006-5439-4051
The Rolf Luft Research center for Diabetes and Endocrinology, Karolinska Institutet, Stockholm 171 76, Sweden.
KTH, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), Protein Science, Nano Biotechnology. KTH, School of Electrical Engineering and Computer Science (EECS), Micro and Nanosystems. KTH, Centres, Science for Life Laboratory, SciLifeLab.ORCID iD: 0000-0002-9144-0065
Show others and affiliations
2026 (English)In: Device, E-ISSN 2666-9986, Vol. 4, no 6, article id 101121Article in journal (Refereed) Published
Abstract [en]

Continuous observation of molecular and cellular dynamics in vivo is critical for understanding disease progression and therapeutic response. Conventional approaches, such as imaging or endpoint assays, are limited by their discontinuous nature and the physiological stress they impose on animal models. Here, we present a minimally invasive millimetric implantable device (5 × 5 × 5 mm3) designed for fully autonomous, continuous in vivo fluorescence tracking. The device integrates a miniaturized optical system with low-power on-board electronics, enabling uninterrupted fluorescence recording in close proximity to the biological source. We validated the device by tracking sustained release and systemic clearance of fluorescein isothiocyanate in vivo over 30 h. We further demonstrated long-term utility by continuously tracking tumor-associated fluorescence in a subcutaneous glioma model for 2 weeks. These results present a compact, self-contained device enabling continuous longitudinal fluorescence sensing in animal models, providing a platform for investigating drug delivery, tumor development, and immunological processes in their native microenvironments.

Place, publisher, year, edition, pages
Elsevier BV , 2026. Vol. 4, no 6, article id 101121
Keywords [en]
DTI-3: develop, biomedical sensors, fluorescence recording, implantable sensor, in vivo, integrated microsystem, optical biosensor
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:kth:diva-384375DOI: 10.1016/j.device.2026.101121Scopus ID: 2-s2.0-105042084104OAI: oai:DiVA.org:kth-384375DiVA, id: diva2:2082125
Note

QC 20260630

Available from: 2026-06-30 Created: 2026-06-30 Last updated: 2026-06-30Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textScopus

Authority records

Tian, XuSpyrou, ArgyrisKavand, HanieStemme, GöranRoxhed, Niclas

Search in DiVA

By author/editor
Tian, XuSpyrou, ArgyrisKavand, HanieStemme, GöranRoxhed, Niclas
By organisation
Micro and NanosystemsNano BiotechnologyScience for Life Laboratory, SciLifeLab
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 8 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf